Carmine N. Stengone sold $40K of Contineum Therapeutics, Inc. (CTNM) stock

Carmine N. Stengone, CEO and President of Contineum Therapeutics, Inc. (CTNM), sold 2,500 shares of CTNM stock worth $40K, per an SEC Form 4 filed Aug 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Aug 3, 2026.

CTNM has moved -14.9% since the trade date, from $15.93 to $13.55 (Sep 21, 2026 close).